Chinese biotechnology stocks rallied on Tuesday, driven by better-than-expected earnings from key players and investors seeking defensive sectors ahead of the looming US tariffs.
Alaris Equity Partners Income Trust Declares Q4 Distribution
...
Read moreDetails



